Acorah Software Products - Accounts Production 15.0.400 false true 31 October 2022 27 October 2021 false true No description of principal activity 1 November 2022 31 October 2023 31 October 2023 13708104 Miss Davina Rana iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13708104 2022-10-31 13708104 2023-10-31 13708104 2022-11-01 2023-10-31 13708104 frs-core:CurrentFinancialInstruments 2023-10-31 13708104 frs-bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 13708104 frs-bus:FilletedAccounts 2022-11-01 2023-10-31 13708104 frs-bus:Micro-entities 2022-11-01 2023-10-31 13708104 frs-bus:AuditExempt-NoAccountantsReport 2022-11-01 2023-10-31 13708104 frs-bus:Director1 2022-11-01 2023-10-31 13708104 2021-10-26 13708104 2022-10-31 13708104 2021-10-27 2022-10-31 13708104 frs-core:CurrentFinancialInstruments 2022-10-31
Registered number: 13708104
RANA PHARMACEUTICALS LTD
Unaudited Financial Statements
For The Year Ended 31 October 2023
Balance Sheet
Registered number: 13708104
2023 2022
£ £
Fixed assets 2,786 1,200
Current assets 34,973 41,052
Creditors: Amounts Falling Due Within One Year (11,794 ) (25,417 )
NET CURRENT ASSETS 23,179 15,635
TOTAL ASSETS LESS CURRENT LIABILITIES 25,965 16,835
NET ASSETS 25,965 16,835
CAPITAL AND RESERVES 25,965 16,835

Notes

1. General Information
RANA PHARMACEUTICALS LTD is a private company, limited by shares, incorporated in England & Wales, registered number 13708104 . The registered office is 40 Plashet Road, London, England, E13 0PU.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2022: 1)
1 1
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Miss Davina Rana
Director
30/12/2023